• Antibody Discovery HEK293

UNISELECT™ Antibody Discovery and Screening

UNISELECT™ Mammalian Cell-Based Membrane Proteins Antibody Discovery & Screening! Applied StemCell provides Custom TARGATT™ Master Cell Generation in your cell lines, and ready-to-use TARGATT™ HEK293, and TARGATT™CHO  to build protein libraries using site-specific transgene integration at a preselected safe harbor locus.

This is a fast, unique and efficient platform for biopanning, including bispecific mAbs, antibody discovery/ screening, membrane proteins, CAR-T cell screening, and for bioprocessing.

  • Single copy integration
  • Homogenous expression of protein variants
  • Preselected safe harbor locus
  • Stable protein expression
  • No bacterial backbone insertion
  • Inducible expression compatible for membrane proteins (optional)
Products and Services

3 Items

per page
Application Notes

TARGATT™ System in HEK293T Cells


Antibody Discovery Site-Specific Gene Insertion Using TARGATT™ Master Cell Lines

Figure 1. Schematic representation of site-specific gene insertion using TARGATT™ Master Cell Lines. The TARGATT™ Master Cell Line is engineered with the attP landing pad (or docking site) at a preselected safe harbor locus (hROSA26). The TARGATT™ PhiC31 integrase catalyzes an irreversible reaction between the attP sites on genome and the attB sites on the donor vector, resulting in integration of a single copy of the GFP reporter gene at the locus.

 Antibody Discovery Showing GFP expression in hROSA26 locus

Figure 2. GFP expression in hROSA26 locus in TARGATT™ HEK293T Master Cell Lines. The CAG-GFP vector was used to verify a fast knock-in in the TARGATT™-HEK293T Master Cell Line. An enriched GFP signal was shown under fluorescence microscopy. (Left) bright field microscopy. (Right) Immunofluorescence; GFP channel.


Figure 3. TARGATT™-HEK293T Master Cell Line transfected with donor plasmid containing GFP and attB. (a) Parental HEK293T cell line only (control); (b) Parental HEK293T cell line was transfected with donor plasmid containing GFP reporter by random insertion (+GFP); (c) TARGATT™-HEK293T Master Cell Line was transfected with GFP donor plasmid before ganciclovir (GCV) selection (GFP+); (d) TARGATT™-HEK293T Master Cell Line was transfected with GFP donor plasmid after GCV negative selection to eliminate clones without gene of interest (GFP+GCV). The data indicates that the TARGATT™-HEK293 Master Cell Line system provides a robust, fast and efficient integration platform for generating a uniform cell population with stable transgene expression in the hROSA26 locus. This platform paves the way for homogeneous expression of gene of interest and subsequent protein production.

TARGATT™ System in CHO Cells


Figure 4. TARGATT™-CHO Master Cell Line with GFP transgene integration into the hH11 locus. GFP signal was detected by fluorescence imaging after transfection with donor construct by random insertion in bright field (a) and GFP channel (b), and TARGATT™ integration plus GCV selection in bright field (c) and GFP channel (d).


How does the TARGATT™ gene integration technology compare to the Flp-In™ System?
Can you generate a master cell line with the cell line I am interested?
Can you generate a master cell line with docking site at a different locus?
Can we avoid ganciclovir selection?
What is the level of concordance between different TARGATT™ lines?
What is the size or diversity of the antibody library that can be made with the TARGATT™ HEK293T Line, and at what scale of transfection (number of cells used in transfection)?
Technical Details

The TARGATT™ Knock-in Master Cell Line Kit uses PhiC31 integrase to insert any gene of interest into a preselected intergenic and transcriptionally active genomic locus (hROSA26, hH11, or other pre-defined safe harbor loci). The TARGATT™ technology can be utilized for generating knock-in cell lines and libraries for a variety of applications including reporter gene expression, gene knockdown, conditional/ inducible gene expression, gene overexpression, expression libraries for antibody discovery/ screening, bioproduction of recombinant protein, and disease modeling.

Comparing TARGATT™ with lentivirus-based mammalian cell libraries



Figure 1. Schematic representation of a lentiviral method of generating a mammalian cell library.



Figure 2.  Schematic representation of the TARGATT™ method of generating a mammalian cell library. The process is very similar to lentiviral library but more efficient.


Applications for Cell-Based Library Screening

Antibody discovery:

  • Biopanning (scFv screening)
  • Off-target screening with membrane protein library
  • Bioprocessing

Immuno-oncology (CAR-T cells):

  • CAR affinity/ efficiency screening
  • CAR specificity screening for safety assessment
  • “Universal” CAR-T cell
  • Novel immune target discovery: biomarkers and checkpoints

Receptor identification 

  • Ion channels
  • GPCR

Protein evolution           

  • Enzyme activity and specificity
  • AAV capsid specificity and efficiency


  • Off-target screening
  • Non-membrane, non-secretary protein library

TARGATT™ Technology Applications:

Have Questions?

An Applied StemCell technical expert is happy to help, contact us today!